ArticleThe archives of bone and joint surgery2025
Drug Repurposing for Frozen Shoulder; a Bioinformatics Meta-Analysis.
Article in The archives of bone and joint surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Adhesive capsulitis (AC), commonly known as frozen shoulder (FS), is characterized by glenohumeral joint capsule contraction, resulting in pain, stiffness, and dysfunction. Genetic factors have been implicated in the etiology of AC, prompting a bioinformatics investigation to explore potential therapeutic targets. Methods: A systematic review of Gene Expression Omnibus (GEO) datasets was conducted using keywords related to Frozen Shoulder and Adhesive Capsulitis. The gene expression profiles from GSE238052, GSE190023, and GSE140731 were analyzed using the i-DEP package. Differential gene expression analysis, Gene Ontology (GO) enrichments, and drug-gene enrichments were performed through biclustering of GO pathways with the Drug.GeneSet database and dpGSEA Python application. Results: Among 58,825 genes in 67 samples, 1,036 upregulated and 378 downregulated genes were identified in the case-control comparison. Upregulated pathways included skeletal muscle adaptation, fiber transition, myofibril assembly, and regulation of muscle fiber development. Drug.GeneSet database analysis highlighted adenosine and its derivatives as potential therapeutic targets. Further dpGSEA analysis revealed a significant influence of adenosine on the disease. Conclusion: This study provides information about the genomic landscape of adhesive capsulitis, identifying potential therapeutic avenues centered around adenosine-related interventions. While topical or intra-articular injection of adenosine is evident in the literature, this finding should be validated through experimental studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.